Literature DB >> 7494612

Lipid peroxidation as an indicator of biocompatibility in haemodialysis.

T Sanaka1, C Higuchi, T Shinobe, H Nishimura, M Omata, H Nihei, N Sugino.   

Abstract

Peroxidation of cell membrane (phosphatidylcholine hydroperoxide, PCOOH) was quantitatively assessed using a chemiluminescence-HPLC system to clarify whether haemodialysis patients are damaged by oxidative stress. Patients were divided into two groups, one dialysed with conventional cellulose membranes, and the other with cellulose triacetate for 3 months, subsequently followed by a crossover study of each membrane for 3 more months. The mean value of PCOOH in haemodialysis patients was 508.5 +/- 208.7 pmol/ml (P < 0.01 vs normal controls), which showed a statistically insignificant tendency to increase during each haemodialysis session of 4 h. Two years after commencing haemodialysis, PCOOH was maintained within almost the same range, but significantly greater than normal. There was no significant tendency between an index of aortic sclerosis and plasma PCOOH. However, three patients using conventional cellulose membranes died of myocardial infarction. Plasma PCOOH increased after the commencement of haemodialysis. This tendency was more notable in patients using conventional cellulose membrane compared to the cellulose triacetate. Cellulose triacetate, which we thought to be more biocompatible, did not necessarily produce lipid peroxide. We conclude that it is very important to check production of oxygen radicals when developing new membranes.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7494612     DOI: 10.1093/ndt/10.supp3.34

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN: 0931-0509            Impact factor:   5.992


  3 in total

1.  Activation of platelets upon contact with a vitamin E-coated/non-coated surface.

Authors:  Hiroshi Tsukao; Kenichi Kokubo; Haruko Takahashi; Mina Nagasato; Takanori Endo; Naoto Iizuka; Toshihiro Shinbo; Minoru Hirose; Hirosuke Kobayashi
Journal:  J Artif Organs       Date:  2013-02-05       Impact factor: 1.731

Review 2.  Cellulose, modified cellulose and synthetic membranes in the haemodialysis of patients with end-stage renal disease.

Authors:  A M Macleod; M Campbell; J D Cody; C Daly; C Donaldson; A Grant; I Khan; K S Rabindranath; L Vale; S Wallace
Journal:  Cochrane Database Syst Rev       Date:  2005-07-20

3.  Administration of antioxidants in chronic kidney disease.

Authors:  Mohamad Reza Tamadon; Mehrdad Zahmatkesh; Seyed Seifollah Beladi Mousavi
Journal:  J Nephropharmacol       Date:  2015-01-01
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.